21 research outputs found

    Comparison of Melanoma Subtypes among Korean Patients by Morphologic Features and Ultraviolet Exposure

    Get PDF
    BACKGROUND: Genetic alterations have been identified in melanomas according to different levels of sun exposure. Whereas the conventional morphology-based classification provides a clue for tumor growth and prognosis, the new classification by genetic alterations offers a basis for targeted therapy. OBJECTIVE: The purpose of this study is to demonstrate the biological behavior of melanoma subtypes and compare the two classifications in the Korean population. METHODS: A retrospective chart review was performed on patients found to have malignant melanoma in Severance Hospital from 2005 to 2012. Age, sex, location of the tumor, histologic subtype, tumor depth, ulceration, lymph node invasion, visceral organ metastasis, and overall survival were evaluated. RESULTS: Of the 206 cases, the most common type was acral melanoma (n=94, 45.6%), followed by nonchronic sun damage-induced melanoma (n=43, 20.9%), and mucosal melanoma (n=40, 19.4%). Twenty-one patients (10.2%) had the chronic sun-damaged type, whereas eight patients (3.9%) had tumors of unknown primary origin. Lentigo maligna melanoma was newly classified as the chronic sun-damaged type, and acral lentiginous melanoma as the acral type. More than half of the superficial spreading melanomas were newly grouped as nonchronic sun-damaged melanomas, whereas nodular melanoma was rather evenly distributed. CONCLUSION: The distribution of melanomas was largely similar in both the morphology-based and sun exposure-based classifications, and in both classifications, mucosal melanoma had the worst 5-year survival owing to its tumor thickness and advanced stage at the time of diagnosis.ope

    ํŒŒ์šฐ์ŠคํŠธ์  ์งˆ๋ฌธ๊ณผ ๋˜๊ณผ ํ—ˆ๋ฒ„ํŠธ์˜ ์ข…๊ต์‹œ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ) --์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์˜์–ด์˜๋ฌธํ•™๊ณผ,2008.Maste

    Effect of Korea's Entertainment Culture on the Fashion of the College Students

    No full text

    CESCO์˜ e-marketing "๋ฌด์—‡์ด๋“  ๋ฌผ์–ด๋ณด์„ธ์š”"

    No full text
    ์ถœ๊ทผํ•˜์ž๋งˆ์ž ํšŒ์‚ฌ ํ™ˆํŽ˜์ด์ง€์˜ Q&A ๊ฒŒ์‹œํŒ์„ ์ฒดํฌํ•˜๋˜ ์ „์ฐฌํ˜ ์ƒ๋ฌด๋Š”, ๊ธฐ์ˆ ์—ฐ๊ตฌ์†Œ์˜ ํ•œ ์ง์›์ด ์˜ฌ๋ฆฐ ๋‹ต๋ณ€์„ ๋ณด๋ฉฐ ๋ฏธ์†Œ๋ฅผ ์ง€์—ˆ๋‹ค ๋ฐ”ํ€ด ๊ณต์ฃผ๊ฐ€ ๋“ฑ์žฅํ•˜๋Š” ๊ณ ๊ฐ์˜ ์งˆ๋ฌธ์€ ์—‰๋šฑํ–ˆ์ง€๋งŒ, ๋‹ต๋ณ€์„ ์˜ฌ๋ฆฐ ์ง์›์€ ์งˆ๋ฌธ์„ ๋ฌด์‹œํ•˜๊ฑฐ๋‚˜, ๋‹นํ™ฉํ•œ ํ”์ ์ด ์—†์—ˆ๋‹ค ์˜คํžˆ๋ ค ๊ณ ๊ฐ์˜ ์งˆ๋ฌธ์— ์ž˜ ๋Œ€์‘ํ•˜๊ณ  ์žˆ์—ˆ๋‹ค ๋‹ต๋ณ€์€ ์ ๋‹นํ•˜๊ฒŒ ์žฌ์น˜์žˆ๊ณ , ์žฌ๋ฏธ์žˆ์—ˆ๋‹ค ๊ฐ€๋ฒผ์šด ์œ ๋จธ๋กœ ํ๋ฅด๋Š” ๊ฒƒ์„ ๋ง‰๊ธฐ ์œ„ํ•ด ๋ฐ”ํ€ด๋ฒŒ๋ ˆ์— ๋Œ€ํ•œ ์ „๋ฌธ์ ์ธ ์ง€์‹๋„ ๊ณ๋“ค์–ด์ ธ ์žˆ์—ˆ๋‹ค. 2000๋…„์— ์ฒ˜์Œ ํšŒ์‚ฌ ํ™ˆํŽ˜์ด์ง€๋ฅผ ๋งŒ๋“ค์—ˆ์„ ๋•Œ๋งŒ ํ•ด๋„ ์˜์•„ํ•ด ํ•˜๋Š” ์‚ฌ๋žŒ๋“ค์ด ๋งŽ์•˜์Šต๋‹ˆ๋‹ค. ๋ฒŒ๋ ˆ ์žก๊ณ  ์ฅ ์žก๋Š” ํ•ด์ถฉ ๋ฐฉ์ œ ํšŒ์‚ฌ์™€ ์ธํ„ฐ๋„ท์˜ ํ™ˆํŽ˜์ด์ง€๋Š” ์–ด์šธ๋ฆฌ์ง€ ์•Š๋Š”๋‹ค๊ณ  ์ƒ๊ฐํ•œ ์‚ฌ๋žŒ๋“ค์ด ๋งŽ์•˜์œผ๋‹ˆ๊นŒ์š”. ํ•˜์ง€๋งŒ ์ด์   ๋Œ€๋ถ€๋ถ„์˜ ์‚ฌ๋žŒ๋“ค์€ ์„ธ์Šค์ฝ” ํ•˜๋ฉด ๊ฒŒ์‹œํŒ์˜ ์„ฑ๊ณต์„ ๋จผ์ € ๋– ์˜ฌ๋ฆด ๊ฒƒ์ž…๋‹ˆ๋‹ค. ์ธํ„ฐ๋„ท์ด ๋งˆ์ผ€ํŒ…์˜ ์ˆ˜๋‹จ์œผ๋กœ์จ ์ค‘์š”ํ•œ ์—ญํ• ์„ ์ฐจ์ง€ํ•˜๊ฒŒ ๋˜๋ฉด์„œ ๊ธฐ์—…๋“ค์˜ ํ™ˆํŽ˜์ด์ง€๋Š” ์šฐํ›„์ฃฝ์ˆœ์ฒ˜๋Ÿผ ๋Š˜์–ด๋‚ฌ์ง€๋งŒ, ๊ทธ ์ˆ˜๋งŽ์€ ํ™ˆํŽ˜์ด์ง€ ์ค‘์—์„œ ์„ธ์Šค์ฝ”์˜ ๊ฒŒ์‹œํŒ ๊ด€๋ฆฌ๋Š” ํ˜๋ช…์ ์ด๋ผ๊ณ  ๋ถˆ๋ฆด ์ •๋„์˜€์œผ๋‹ˆ ๊ธฐ๋Œ€์ด์ƒ์˜ ์„ฑ๊ณต์„ ๊ฑฐ๋‘” ์…ˆ์ด์ฃ . ๋ผ๊ณ  ๋งํ•˜๋ฉฐ ์ „ ์ƒ๋ฌด๋Š” ์ฒ˜์Œ ํ™ˆํŽ˜์ด์ง€๋ฅผ ๊ณ„ํšํ–ˆ๋˜ 2000๋…„์˜ ์ƒํ™ฉ์„ ๋– ์˜ฌ๋ ธ๋‹ค

    Efficacy of allergen-specific immunotherapy for atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials

    No full text
    BACKGROUND: Allergen-specific immunotherapy (allergen-SIT) is the only treatment directed at the cause of IgE-mediated allergic diseases. However, there is controversy over the use of SIT for patients with atopic dermatitis. OBJECTIVE: We performed a systematic review and meta-analysis to assess the efficacy of SIT for patients with atopic dermatitis. METHODS: We performed manual searches of reference lists and computerized searches of the MEDLINE, EMBASE, CINAHL, Web of Science, and Cochrane databases (through December 10, 2012) for randomized controlled trials that compared SIT with placebo for patients with atopic dermatitis. The outcome of interest was a dichotomous variable, in terms of treatment success; a meta-analysis was performed by using a random-effects analysis. Subgroup analyses were carried out to evaluate the effects of long-term treatment (more than 1 year), SIT for severe atopic dermatitis, SIT for children, and subcutaneous and sublingual administration of immunotherapy. RESULTS: We analyzed 8 randomized controlled trials that comprised a total of 385 subjects. We found that SIT has a significant positive effect on atopic dermatitis (odds ratio [OR], 5.35; 95% CI, 1.61-17.77; number needed to treat, 3; 95% CI, 2-9). SIT also showed significant efficacy in long-term treatment (OR, 6.42; 95% CI, 1.50-27.52) for patients with severe atopic dermatitis (OR, 3.13; 95% CI, 1.31-7.48), and when administered subcutaneously (OR, 4.27; 95% CI, 1.36-13.39). CONCLUSIONS: A meta-analysis provides moderate-level evidence for the efficacy of SIT against atopic dermatitis. However, these findings are based on an analysis of a small number of randomized controlled trials, with considerable heterogeneity among trials.ope

    Mohs micrographic surgery for extramammary Paget disease: A pooled analysis of individual patient data

    No full text
    BACKGROUND: Extramammary Paget disease (EMPD) is a rare intraepithelial neoplasm of the skin characterized by ill-defined margins and high recurrence rates after wide local excision. Although Mohs micrographic surgery (MMS) has been proposed to decrease the rate of local recurrence, the efficacy of MMS for this condition has not yet been established. OBJECTIVE: We sought to assess the efficacy of MMS for the treatment of EMPD. METHODS: A comprehensive systematic review and individual patient data meta-analysis was performed including all available clinical studies and case reports with 5 or more subjects describing the use of MMS for EMPD. RESULTS: Eight studies were identified and included in the current review: 3 retrospective studies and 5 case series. In all, 81 patients with 90 cases of MMS were included from these 8 studies. The overall recurrence rate for EMPD after MMS was 12.2% correlating with an estimated 5-year tumor-free rate of 83.6% by using Kaplan-Meier curve analysis. The treatment of EMPD with MMS resulted in significantly lower recurrence rates than wide local excision in this meta-analysis of 3 observational studies with comparators (odds ratio 0.20; 95% confidence interval 0.05-0.81). LIMITATIONS: Limitations include lack of controlled trials, small sample sizes in the included studies, and publication bias. CONCLUSION: The current evidence supports the efficacy of MMS in the treatment of EMPD. Further controlled clinical trials are needed.ope

    Comparing the short-term outcomes of totally intracorporeal gastroduodenostomy with extracorporeal gastroduodenostomy after laparoscopic distal gastrectomy for gastric cancer: a single surgeonโ€™s experience and a rapid systematic review with meta-analysis

    No full text
    BACKGROUND: Since delta-shaped gastroduodenostomy was introduced, many surgeons have utilized laparoscopic distal gastrectomy (LDG) with totally intracorporeal Billroth I (ICBI) for gastric cancer, because it is expected to have several advantages over laparoscopic-assisted distal gastrectomy with extracorporeal Billroth I (ECBI). In this study, we compared these two reconstruction options to evaluate their outcomes. METHODS: The data of 166 gastric cancer patients who underwent LDG performed by a single surgeon between April 2009 and February 2012 were analyzed retrospectively. The subjects were divided into ECBI (n = 106) and ICBI (n = 60) groups, and then the clinical characteristics, surgical outcomes, symptoms, and change in BMI at 3 months after surgery were compared. Furthermore, a rapid systematic review and meta-analysis were conducted. RESULTS: The operative time was significantly shorter in the ICBI group (197.4 ยฑ 45.5 vs. 157.1 ยฑ 43.9 min), but blood loss was similar between the groups. Regarding surgical outcomes, there were no significant differences in the length of hospital stay, soft diet initiation, visual analogue scale, frequency of analgesics injection, and postoperative white blood cell counts and C-reactive protein levels between the groups. The surgical complication rates were 5.7 and 13.3% in the ECBI and ICBI groups, respectively, and one case of anastomosis leakage was observed in each group. At 3 months after surgery, reflux symptoms were more frequent in the ICBI group, but other gastrointestinal symptoms and the change of BMI were similar between the groups. The meta-analysis revealed no significant differences in the operative time, time to first flatus, length of hospital stay, frequency of analgesic usages, and rates of anastomosis complications between the groups. CONCLUSIONS: We could not demonstrate the clinical superiority of ICBI over ECBI based on our data and a rapid systematic review and meta-analysis. The anastomosis method may be selected according to patient conditions and the surgeon's preference.ope
    corecore